Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

For instance, median IL-6 levels were 3.65 pg/mL in node-positive patients and 2.93 pg/mL in node-negative patients (p = 0.082), while median vitamin D levels were 19.59 ng/mL and 24.13 ng/mL, respectively (p = 0.130).

Source: 3.2. Nodal Metastasis Is Associated Predominantly with Local Histopathological Aggressiveness. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis

Study design awaiting verification · Journal of Clinical Medicine · 2026

Original publication title

Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis

Vlad-Petre Atanasescu; Valentin Titus Grigorean; Raluca Florentina Tulin; Maria Fulina; Matei Șerban; Răzvan-Adrian Covache-Busuioc; Corneliu Toader; Alexandru Vlad Ciurea; Anamaria Oproiu

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Lymph-node metastasis remains central to staging, prognosis, surveillance, and treatment planning in malignant melanoma. At present, most statistical models assessing nodal metastatic risk in malignant melanoma consider pathological descriptors, inflammatory markers, metabolic alterations, clinical data, and related variables independently of each other. Therefore, we developed a transparent artificial intelligence (AI)-based approach to assess whether the propensity for nodal metastasis is determined by a single layer of local histopathological aggressiveness or by the integration of different biological levels, including local histopathological aggressiveness, systemic inflammatory: metabolic dysregulation, biological heterogeneity, or a clinicobiological pattern.

Methods:

In this retrospective study, we assessed 73 adult patients undergoing surgical removal of malignant melanoma. The primary endpoint was histopathologically confirmed lymph-node metastasis. Routinely collected patient-related data, including clinical, anatomical, operative, histopathological, nodal, comorbidity, biological, clinical course, and available staging data, were structured into interpretable constructs. These included the Histopathologic Aggressiveness Index (HAI), the Inflammatory: Metabolic Dysregulation Index (IMDI), the Biological: Histological Discordance Score (BHDS), model-estimated nodal metastatic probability, integrated clinicobiological risk, and explanation stability. The AI-based framework was evaluated by applying bias-reduced and penalized logistic regression, machine learning benchmarking, leave-one-out cross-validation, bootstrap estimation, permutation testing, decision curve analysis, rule extraction, feature stability evaluation, network analysis, similarity-based retrieval, conformal uncertainty estimation, and unsupervised phenomapping.

Results:

For 72 out of 73 patients, nodal histopathology results were available. Among these patients, 22 had positive nodal status. Positive nodal status was associated with a higher Breslow thickness, an increased mitotic rate, ulceration, lymphovascular invasion, a nodular subtype, and palpable adenopathy. The HAI demonstrated the strongest discriminative signal between node-positive and node-negative patients (median values of 67.8 vs. 45.3; p < 0.001) and retained an independent association with nodal metastasis within the bias-reduced logistic model (odds ratio [OR] per 10-point increase: 2.74; 95% confidence interval [CI]: 1.58 to 4.75; p < 0.001). The IMDI showed a weak exploratory relationship and did not retain an independent association after adjustment. Similarly, the BHDS did not show significant differences in separating the two endpoint groups. The penalized logistic model including only the HAI showed good performance under leave-one-out cross-validation, with ROC AUC = 0.889, PR-AUC = 0.706, and Brier score = 0.137. Through rule extraction, we found a cohort-specific HAI threshold value > 58.6, above which all node-positive cases were located. With respect to explainability, feature stability, network analysis, similarity retrieval, conformal prediction, and phenomapping, there was convergence toward a dominant high-risk phenotype defined primarily by histopathological criteria.

Conclusions:

Routine melanoma registries may be transformed into internally evaluated melanoma intelligence frameworks. Histopathologically confirmed lymph-node metastasis among patients with malignant melanoma was organized primarily along an axis of local histopathological aggressiveness, while systemic inflammatory: metabolic dysregulation provided subordinate contextual biological information.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Lymph-node metastasis remains central to staging, prognosis, surveillance, and treatment planning in malignant melanoma. At present, most statistical models assessing nodal metastatic risk in malignant melanoma consider pathological descriptors, inflammatory markers, metabolic alterations, clinical data, and related variables independently of each other. Therefore, we developed a transparent artificial intelligence (AI)-based approach to assess whether the propensity for nodal metastasis is determined by a single layer of local histopathological aggressiveness or by the integration of different biological levels, including local histopathological aggressiveness, systemic inflammatory: metabolic dysregulation, biological heterogeneity, or a clinicobiological pattern.

Source: Background/Objectives:

Abstract: Results

For 72 out of 73 patients, nodal histopathology results were available. Among these patients, 22 had positive nodal status. Positive nodal status was associated with a higher Breslow thickness, an increased mitotic rate, ulceration, lymphovascular invasion, a nodular subtype, and palpable adenopathy. The HAI demonstrated the strongest discriminative signal between node-positive and node-negative patients (median values of 67.8 vs. 45.3; p < 0.001) and retained an independent association with nodal metastasis within the bias-reduced logistic model (odds ratio [OR] per 10-point increase: 2.74; 95% confidence interval [CI]: 1.58 to 4.75; p < 0.001). The IMDI showed a weak exploratory relationship and did not retain an independent association after adjustment. Similarly, the BHDS did not show significant differences in separating the two endpoint groups. The penalized logistic model including only the HAI showed good performance under leave-one-out cross-validation, with ROC AUC = 0.889, PR-AUC = 0.706, and Brier score = 0.137. Through rule extraction, we found a cohort-specific HAI threshold value > 58.6, above which all node-positive cases were located. With respect to explainability, feature stability, network analysis, similarity retrieval, conformal prediction, and phenomapping, there was convergence toward a dominant high-risk phenotype defined primarily by histopathological criteria.

Source: Results:

Abstract: Conclusions

Routine melanoma registries may be transformed into internally evaluated melanoma intelligence frameworks. Histopathologically confirmed lymph-node metastasis among patients with malignant melanoma was organized primarily along an axis of local histopathological aggressiveness, while systemic inflammatory: metabolic dysregulation provided subordinate contextual biological information.

Source: Conclusions:
Authors’ abstract

Background/Objectives:

Lymph-node metastasis remains central to staging, prognosis, surveillance, and treatment planning in malignant melanoma. At present, most statistical models assessing nodal metastatic risk in malignant melanoma consider pathological descriptors, inflammatory markers, metabolic alterations, clinical data, and related variables independently of each other. Therefore, we developed a transparent artificial intelligence (AI)-based approach to assess whether the propensity for nodal metastasis is determined by a single layer of local histopathological aggressiveness or by the integration of different biological levels, including local histopathological aggressiveness, systemic inflammatory: metabolic dysregulation, biological heterogeneity, or a clinicobiological pattern.

Methods:

In this retrospective study, we assessed 73 adult patients undergoing surgical removal of malignant melanoma. The primary endpoint was histopathologically confirmed lymph-node metastasis. Routinely collected patient-related data, including clinical, anatomical, operative, histopathological, nodal, comorbidity, biological, clinical course, and available staging data, were structured into interpretable constructs. These included the Histopathologic Aggressiveness Index (HAI), the Inflammatory: Metabolic Dysregulation Index (IMDI), the Biological: Histological Discordance Score (BHDS), model-estimated nodal metastatic probability, integrated clinicobiological risk, and explanation stability. The AI-based framework was evaluated by applying bias-reduced and penalized logistic regression, machine learning benchmarking, leave-one-out cross-validation, bootstrap estimation, permutation testing, decision curve analysis, rule extraction, feature stability evaluation, network analysis, similarity-based retrieval, conformal uncertainty estimation, and unsupervised phenomapping.

Results:

For 72 out of 73 patients, nodal histopathology results were available. Among these patients, 22 had positive nodal status. Positive nodal status was associated with a higher Breslow thickness, an increased mitotic rate, ulceration, lymphovascular invasion, a nodular subtype, and palpable adenopathy. The HAI demonstrated the strongest discriminative signal between node-positive and node-negative patients (median values of 67.8 vs. 45.3; p < 0.001) and retained an independent association with nodal metastasis within the bias-reduced logistic model (odds ratio [OR] per 10-point increase: 2.74; 95% confidence interval [CI]: 1.58 to 4.75; p < 0.001). The IMDI showed a weak exploratory relationship and did not retain an independent association after adjustment. Similarly, the BHDS did not show significant differences in separating the two endpoint groups. The penalized logistic model including only the HAI showed good performance under leave-one-out cross-validation, with ROC AUC = 0.889, PR-AUC = 0.706, and Brier score = 0.137. Through rule extraction, we found a cohort-specific HAI threshold value > 58.6, above which all node-positive cases were located. With respect to explainability, feature stability, network analysis, similarity retrieval, conformal prediction, and phenomapping, there was convergence toward a dominant high-risk phenotype defined primarily by histopathological criteria.

Conclusions:

Routine melanoma registries may be transformed into internally evaluated melanoma intelligence frameworks. Histopathologically confirmed lymph-node metastasis among patients with malignant melanoma was organized primarily along an axis of local histopathological aggressiveness, while systemic inflammatory: metabolic dysregulation provided subordinate contextual biological information.

Publication and source details

Original title: Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis

Vlad-Petre Atanasescu; Valentin Titus Grigorean; Raluca Florentina Tulin; Maria Fulina; Matei Șerban; Răzvan-Adrian Covache-Busuioc; Corneliu Toader; Alexandru Vlad Ciurea; Anamaria Oproiu

Journal of Clinical Medicine · 2026

* Correspondence: valentintitusgrigorean@umfro.com (V.T.G.); florentina.tulin@umfcd.ro (R.F.T.)
†

These authors contributed equally to this work.

© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. University of Medicine and Pharmacy Carol Davilahttps://ror.org/04fm87419 Publication of this paper was supported by the University of Medicine and Pharmacy Carol Davila through the institutional program Publish not Perish.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:42:58.725988+00:00

DOI: 10.3390/jcm15186945 · PMC13607197